Risultati della ricerca - Scott J. Rodig

Raffina i risultati
  1. 1
    Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma

    Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma di Reid W. Merryman, Philippe Armand, Kyle Wright, Scott J. Rodig

    Pubblicazione 2017
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    The biology and treatment of EML4-ALK non-small cell lung cancer

    The biology and treatment of EML4-ALK non-small cell lung cancer di Takaaki Sasaki, Scott J. Rodig, Lucian R. Chirieac, Pasi A. Jänne

    Pubblicazione 2010
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia

    MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia di Richard Byers, Treeve Currie, Eleni Tholouli, Scott J. Rodig, Jeffery L. Kutok

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth

    ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth di Roopali Roy, Scott J. Rodig, Diane R. Bielenberg, David Zurakowski, Marsha A. Moses

    Pubblicazione 2011
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration

    Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration di Michael Kluk, Kieran P. Ryan, Bonnie Wang, Guoqi Zhang, Scott J. Rodig, Teresa Sánchez

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth <i>In Vitro</i> and <i>In Vivo</i>

    Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth <i>In Vitro</i> and <i>In Vivo</i> di Yansheng Hao, Bjoern Chapuy, Stefano Monti, Heather H. Sun, Scott J. Rodig, Margaret A. Shipp

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas

    ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas di Lynette M. Sholl, Heather H. Sun, Mohit Butaney, Chengsheng Zhang, Charles Lee, Pasi A. Jänne, Scott J. Rodig

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging

    Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging di Kyle Wright, Jason L. Weirather, Sizun Jiang, Katrina Kao, Yari Sigal, Anita Giobbie‐Hurder, Margaret A. Shipp, Scott J. Rodig

    Pubblicazione 2023
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

    Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy di Michael R. Green, Scott J. Rodig, Przemysław Juszczyński, Jing Ouyang, Papiya Sinha, Evan A. O’Donnell, Donna Neuberg, Margaret A. Shipp

    Pubblicazione 2012
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features

    AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features di Scott J. Rodig, Jing Ouyang, Przemysław Juszczyński, Treeve Currie, Kenneth Law, Donna Neuberg, Gabriel A. Rabinovich, Margaret A. Shipp, Jeffery L. Kutok

    Pubblicazione 2008
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis

    Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis di Catriona Jamieson, Robert P. Hasserjian, Jason Gotlib, Jorge E. Cortés, Richard M. Stone, Moshe Talpaz, Jürgen Thiele, Scott J. Rodig, Olga Pozdnyakova

    Pubblicazione 2015
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice

    MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice di Michael Kluk, Caleb Ho, Hongbo Yu, Benjamin J. Chen, Donna Neuberg, Paola Dal Cin, Bruce A. Woda, Geraldine S. Pinkus, Scott J. Rodig

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma

    VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma di Xinqi Wu, Anita Giobbie‐Hurder, Xiaoyun Liao, Donald P. Lawrence, David F. McDermott, Jun Zhou, Scott J. Rodig, F. Stephen Hodi

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas

    Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas di Michael Kluk, Bjoern Chapuy, Papiya Sinha, Alyssa Roy, Paola Dal Cin, Donna Neuberg, Stefano Monti, Geraldine S. Pinkus, Margaret A. Shipp, Scott J. Rodig

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4- positive T-cells that are PD-1-negative

    The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4- positive T-cells that are PD-1-negative di Sanjay S. Patel, Jason L. Weirather, Mikel Lipschitz, Ana Lako, Pei-Hsuan Chen, Gabriel K. Griffin, Philippe Armand, Margaret A. Shipp, Scott J. Rodig

    Pubblicazione 2019
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Nodular primary cutaneous melanoma is associated with PD-L1 expression

    Nodular primary cutaneous melanoma is associated with PD-L1 expression di Mara Giavina‐Bianchi, Pedro Giavina‐Bianchi, Mirian Nacagamo Sotto, Scott J. Rodig, Martín C. Mihm, Cyro Festa Neto, Lyn M. Duncan, Jorge Kalil

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Lipocalin 2 promotes breast cancer progression

    Lipocalin 2 promotes breast cancer progression di Jiang Yang, Diane R. Bielenberg, Scott J. Rodig, Robert Doiron, Matthew C. Clifton, Andrew L. Kung, Roland K. Strong, David Zurakowski, Marsha A. Moses

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma

    The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma di Przemysław Juszczyński, Jing Ouyang, Stefano Monti, Scott J. Rodig, Kunihiko Takeyama, Jeremy S. Abramson, Wen Chen, Jeffery L. Kutok, Gabriel A. Rabinovich, Margaret A. Shipp

    Pubblicazione 2007
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain

    Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain di Min Shi, Margaretha G.M. Roemer, Bjoern Chapuy, Xiaoyun Liao, Heather H. Sun, Geraldine S. Pinkus, Margaret A. Shipp, Gordon J. Freeman, Scott J. Rodig

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis

    Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis di Laura Lovato, Simon N. Willis, Scott J. Rodig, Tyler Caron, Stefany Almendinger, Owain W. Howell, Richard Reynolds, Kevin C. O’Connor, David A. Hafler

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: